CLINICAL_TRIALS
trial_result
· 2017-06-02
Clinical Trial Update: An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma [Phase 2]
Summary
Phase 2 trial evaluating dupilumab in adults with moderate-to-severe uncontrolled asthma; results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2017-06-02